1. Sethi B, et al. Twenty Years of Insulin Gla-100: A Systematic
Evaluation of Its Efficacy and Safety in Type 2 Diabetes
Mellitus. Diabetes Ther, 2022; 13:1409–1481. https://doi.org/10.1007/s13300-022-01284-2
3. Cunningham AM, Freeman AM. Glargine Insulin. 2022. https://www.ncbi.nlm.nih.gov/books/NBK557756/
6. FDA. Drugs@FDA: FDA-Approved Drugs. 2023. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021081
9. National Center for Biotechnology Information. PubChem Compound Summary for CID 118984454, Insulin glargine. https://pubchem.ncbi.nlm.nih.gov/compound/Insulin-glargine. Accessed Mar. 19, 2023.
10. MIMS. Lantus. 2023. https://www.mims.com/indonesia/drug/info/lantus
12. Candido R, Wyne K, Romoli E. A review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus. Diabetes Ther, 2018; 9:927–949. https://doi.org/10.1007/s13300-018-0422-4
20. American Society of Health-System Pharmacists. Insulin Glargine. Drugs.com. 2022. https://www.drugs.com/monograph/insulin-glargine.html